Sisonke (Together): OPEN LABEL TRIAL COVID-19

NCT04838795 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

477102

Enrollment

OTHER

Sponsor class

Conditions

SARS (Severe Acute Respiratory Syndrome)

Interventions

BIOLOGICAL: To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine

Sponsor

Wits Health Consortium (Pty) Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]